Team
The Institute for Cancer Research leaders work together with advisory groups to enhance and expand the foundational strengths of the center. The institute is focused on promoting basic discovery, facilitating transdisciplinary collaborative research, improving the drug discovery pipeline and enhancing the movement of discoveries toward application. Our leadership builds on the center’s core strengths and enables us to drive research toward solutions of major cancer issues.
The Executive Committee, comprised of senior leadership and research program leaders, have dedicated their careers to discovering a cure. They drive the institute’s mission and research, meeting monthly to review research progress, set goals and track results.
Senior Leadership
Andrew Mesecar, PhD
Director
Andrea Kasinski, PhD
Deputy Director
Deborah Knapp, MS, DVM
Comparative Oncology Advisor
Dorothy Teegarden, PhD
Associate Director for Training and Education
Pamala Morris, PhD
Associate Director of Inclusive Excellence
Douglas Cuttell, MS, MBA
Managing Director
Executive Committee
Cell Identity and Signaling
Ourania Andrisani, PhD
Program Co-Leader
Majid Kazemian, PhD
Program Co-Leader
Drug Delivery and Molecular Sensing
Yoon Yeo, PhD
Program Co-Leader
Fang Huang, PhD
Program Co-Leader
Targets, Structures and Drugs
John Tesmer, PhD
Program Co-Leader
Herman Sintim, PhD
Program Co-Leader
Deborah Knapp, MS, DVM
Program Co-Leader